Sara Guariglia,  —

Articles by

Metabolic Changes Relating to MS Onset, Progression Focus of Study

A $957,000 grant will support research at the University at BuffaloĀ intoĀ events that precede the onset of neurodegeneration inĀ multiple sclerosis (MS). Specifically, the funding byĀ the U.S. Army Medical Research and Development CommandĀ will be used to investigate possible changes in cell metabolism that lead toĀ disease onset or progression in…

FDA Approves Lupin’s Generic Form of Tecfidera for MS Treatment

Lupin‘s generic equivalent ofĀ Tecfidera has been approved by the U.S. Food and Drug Administration (FDA) for the treatment ofĀ multiple sclerosis (MS), the company announced in a press release. The therapy ā€” dimethyl fumarate delayed-release capsules ā€” is indicated for use in people withĀ clinically…